Cargando…

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report

INTRODUCTION: Paraganglioma (PGL) is a rare neuroendocrine tumor. Currently, the malignancy is defined as the presence of metastatic spread at presentation or during follow-up. Several gene mutations are listed in the pathogenesis of PGL, among which succinate dehydrogenase (SDHX), particularly the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stigliano, Antonio, Lardo, Pina, Cerquetti, Lidia, Aschelter, Anna Maria, Matarazzo, Iolanda, Capriotti, Gabriela, Schiavi, Francesca, Marchetti, Paolo, Nardone, Maria Rosaria, Petrangeli, Elisa, Toscano, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078645/ https://www.ncbi.nlm.nih.gov/pubmed/30045248 http://dx.doi.org/10.1097/MD.0000000000010904

Ejemplares similares

Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer
por: Cerquetti, Lidia, et al.
Publicado: (2021)

Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study
por: Cerquetti, Lidia, et al.
Publicado: (2019)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

On the use of antiangiogenetic medications for retinopathy of prematurity
por: Hård, Anna-Lena, et al.
Publicado: (2011)

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Huang, Yiqiang, et al.
Publicado: (2018)

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
por: Choi, Hye-Ryeon, et al.
Publicado: (2021)

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
por: Bayley, Jean-Pierre, et al.
Publicado: (2009)

Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
por: Sarkadi, Balazs, et al.
Publicado: (2020)

SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes
por: Choat, Heather, et al.
Publicado: (2014)

Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas
por: Bayley, Jean-Pierre, et al.
Publicado: (2022)

Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2016)

Paraganglioma of the tongue with SDHB gene mutation in a patient with Graves’ disease
por: Duran Alvarez, Marcela Adriana, et al.
Publicado: (2019)

A Multifocal Paraganglioma in an African Male Due to an Underlying SDHB Mutation
por: Siddiqui, Nida Mishraz, et al.
Publicado: (2021)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses
por: Lionetto, Luana, et al.
Publicado: (2020)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2006)

Immune Response Regulation by Leishmania Secreted and Nonsecreted Antigens
por: Santarém, Nuno, et al.
Publicado: (2007)

DEFINITION OF THE EXTRACELLULAR SPACE IN SECRETING AND NONSECRETING OXYNTIC CELLS
por: Forte, Trudy M., et al.
Publicado: (1970)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
por: Poplawski, NK, et al.
Publicado: (2012)

Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
por: Hes, Frederik J, et al.
Publicado: (2010)

Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutations
por: Rijken, J. A., et al.
Publicado: (2018)

SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
por: Velusamy, Anand, et al.
Publicado: (2019)

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
por: Liu, Yang, et al.
Publicado: (2020)

SDHB-Associated Paraganglioma Syndrome in Africa—A Need for Greater Genetic Testing
por: Siddiqui, Nida, et al.
Publicado: (2021)

Transaminitis Evaluation Leads to the Incidental Diagnosis of Familial Paraganglioma Due to SDHB Mutation
por: Okafor, Anderson, et al.
Publicado: (2021)

FRI369 SDHB Hereditary Pheochromocytoma Paraganglioma Syndrome With Biochemically Silent Pheochromocytoma
por: Skariah, Annie M, et al.
Publicado: (2023)

Case Report: Giant Paraganglioma of the Skull Base With Two Somatic Mutations in SDHB and PTEN Genes
por: Main, Ailsa Maria, et al.
Publicado: (2022)

SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
por: Manotas, María Carolina, et al.
Publicado: (2023)

Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients
por: Bennedbæk, Marc, et al.
Publicado: (2016)

Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report
por: Chen, Heye, et al.
Publicado: (2020)

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa
por: Gordon, Debra M, et al.
Publicado: (2021)

A SDHB Variant of Unknown Significance in a Patient With a Cardiac Functional Paraganglioma
por: Carafone, Lindsay, et al.
Publicado: (2023)

Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
por: Ammendola, Michele, et al.
Publicado: (2014)

Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity
por: Wu, Xiaoping, et al.
Publicado: (2010)

Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer
por: Dalbeni, Andrea, et al.
Publicado: (2018)

Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore
por: Ting, Kay Reen, et al.
Publicado: (2020)

Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT Scan
por: Maggio, Roberta, et al.
Publicado: (2022)

Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome
por: Graham, Daryl, et al.
Publicado: (2014)

Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation
por: Kamai, Takao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l5mqer6fo0lt29aph8vij7hsl3